NASDAQ:GENE

Delisted

Genetic Technologies Stock News

Healthcare > Medical - Diagnostics & Research

Buy GENE

*Your capital is at risk

$0.765

+0 (+0%)

At Close: Jan 15, 2025

72 Biggest Movers From Friday

12:00am, Monday, 13'th May 2019

Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Thurs., May 9, 2019

02:22pm, Friday, 10'th May 2019

Genetic Technologies Highlights Completion Of Two New Genetic Risk Tests For Colorectal Cancer And For Breast Cancer

12:00am, Friday, 10'th May 2019

Genetic Technologies Reports Received Nasdaq Notification Letter Related To Shareholders' Equity Being Less Than Minimum Specified Amount Of $2.5M; Has 45 Days To Submit Plan To Regain Compliance

12:00am, Friday, 03'rd May 2019

Genetic Technologies Extends Contract With Paul Kasian As Interim CEO Until June 2019

12:00am, Tuesday, 16'th Apr 2019

Genetic Technologies And The Translational Genomics Research Institute Of Phoenix Sign Memorandum Of Understanding To Cooperate In The Development Of A Commercialization Strategy And Infrastructure Development For A Suite Of Polygenic Risk Tests In The US

12:00am, Monday, 15'th Apr 2019

Genetic Technologies Reports Established Asian Operations In Hainan, China

12:00am, Thursday, 11'th Apr 2019

MoU Signed Between Genetic Technologies and The Translational Genomics Research Institute of Phoenix, AZ

12:00am, Sunday, 07'th Apr 2019

71 Biggest Movers From Yesterday

12:00am, Thursday, 28'th Mar 2019

Genetic Technologies Ltd shares trading higher after the company established its Asian operations within the Hainan Free Trade Zone, easing the company's ability to obtain China FDA approval on genetic risk assessment tests.

12:00am, Wednesday, 27'th Mar 2019

Genetic Technologies Entered into Research Collaboration with Two World Renowned Medical Centres; Financial Terms Not Disclosed

12:00am, Friday, 01'st Feb 2019

Genetic Technologies Received Deficiency Notice from Nasdaq Stock Market Dated January 23, 2019

12:00am, Monday, 28'th Jan 2019

Genetic Technologies Provides End of Year Update on the Test Development Program

12:00am, Friday, 21'st Dec 2018

Genetic Technologies Stock News

72 Biggest Movers From Friday

Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Thurs., May 9, 2019

Genetic Technologies Highlights Completion Of Two New Genetic Risk Tests For Colorectal Cancer And For Breast Cancer

Genetic Technologies Reports Received Nasdaq Notification Letter Related To Shareholders' Equity Being Less Than Minimum Specified Amount Of $2.5M; Has 45 Days To Submit Plan To Regain Compliance

Genetic Technologies Extends Contract With Paul Kasian As Interim CEO Until June 2019

Genetic Technologies And The Translational Genomics Research Institute Of Phoenix Sign Memorandum Of Understanding To Cooperate In The Development Of A Commercialization Strategy And Infrastructure Development For A Suite Of Polygenic Risk Tests In The US

Genetic Technologies Reports Established Asian Operations In Hainan, China

MoU Signed Between Genetic Technologies and The Translational Genomics Research Institute of Phoenix, AZ

71 Biggest Movers From Yesterday

Genetic Technologies Ltd shares trading higher after the company established its Asian operations within the Hainan Free Trade Zone, easing the company's ability to obtain China FDA approval on genetic risk assessment tests.

Genetic Technologies Entered into Research Collaboration with Two World Renowned Medical Centres; Financial Terms Not Disclosed

Genetic Technologies Received Deficiency Notice from Nasdaq Stock Market Dated January 23, 2019

Genetic Technologies Provides End of Year Update on the Test Development Program

Genetics Technologies 6-K Shows New Biomedical Blockchain Joint Venture With Blockshine Technology Corp.

Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018

Top Fintech Company